The oncogenic activity of STAT5A is highly dependent on S725 and S779 phosphorylation, and both residues (S726 and S780 in humans) were found to be constitutively phosphorylated in AML, ALL, and CML cells [145]. Here, STAT5A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.